Media
Press Releases
May 14, 2026
Legislative Discussion Draft of Next-Generation U.S. Clinical Development to Accelerate Cures
The United States has long led the world in biomedical discovery, translation into clinical research, and approvals of new cures and life-changing treatments. However, America’s clinical research enterprise has not kept pace and is fragmented and difficult to integrate into care sites. This discussion draft aims to modernize and improve the clinical trials process for faster and more accessible clinical trials in the U.S. For more information or to share a comment on Rep. Auchincloss' Legislati… Continue Reading
May 13, 2026RELEASE: Auchincloss, Warren, Harshbarger, Hawley Reintroduce Bipartisan Legislation to Rein in Pharmacy Benefit Managers (PBMs), Cut Drug Costs
FOR IMMEDIATE RELEASE Contact: Georgina.Burros@mail.house.gov (Auchincloss) RELEASE: Auchincloss, Warren, Harshbarger, Hawley Reintroduce Bipartisan Legislation to Rein in Pharmacy Benefit Managers (PBMs), Cut Drug Costs WASHINGTON, D.C. - Representatives Jake Auchincloss (D-MA) and Diana Harshbarger (R-TN), alongside Senators Elizabeth Warren (D-MA) and Josh Hawley (R-MO), reintroduced the Patients Before Monopolies (PBM) Act with expanded bipartisan support to rein in drug pricing middlemen… Continue Reading
April 21, 2026RELEASE: Congressman Auchincloss questions Secretary Kennedy on FDA whistleblower disclosures, White House fast-tracking of psychedelics
FOR IMMEDIATE RELEASE: Contact: Georgina.Burros@mail.house.gov (Auchincloss) WASHINGTON, D.C. - Today, Congressman Jake Auchincloss (D, MA-04) questioned Health and Human Services Secretary Robert F. Kennedy Jr. at a House Energy and Commerce Health Subcommittee hearing about the recent decision by the Food and Drug Administration (FDA) to fast track three approvals for psychedelics under the Commissioner’s National Priority Voucher (CNPV) program, based on a text Joe Rogan sent to President T… Continue Reading
In The News
June 02, 2026
Cong. Auchincloss Sees Energy Hope in Hot Rocks
Quaise Energy is advancing plans to build the world’s first commercial-scale superhot geothermal power plant, with initial construction underway in Oregon and operations targeted as early as 2030, according to company materials and research presented at the 2026 Stanford Geothermal Workshop . The project, known as Project Obsidian, aims to tap underground rock exceeding 300°C to generate constant, carbon-free electricity. Early analysis suggests the first phase could produce at least 50 megawat… Continue Reading
May 25, 2026Congressional Proposal Would Expand US FDA Role In Clinical Trials Embedded In Routine Care
Rep. Jake Auchincloss, D-MA, said the goal is to finalize the proposal this fall after stakeholder feedback and attach the package to the next FDA user fee reauthorization bill. Key Takeaways A bipartisan proposal led by Rep. Jake Auchincloss would place the FDA at the center of a federal effort to embed clinical trials into routine care through reusable point-of-care trial networks. The proposal would direct the FDA to modernize IRB oversight and research governance, as well as estab… Continue Reading
May 17, 2026Democrat Can’t Believe Pharmacist Colleague Is Defending RFK Jr.
Rep. Jake Auchincloss accused Kennedy of leading an "anti-vax crusade" during a heated back-and-forth with GOP Rep. Buddy Carter. In a fiery debate about Secretary Robert F. Kennedy Jr. and his stance on vaccines, Rep. Jake Auchincloss (D-Mass.) urged his colleague, Rep. Buddy Carter (R-Ga.), to remember his pharmacist credentials. During a roundtable on CNN’s Sunday episode of “State of the Union,” Auchincloss accused Kennedy of leading an “anti-vax crusade” as the head of Health and Human Se… Continue Reading